Blue Jet Healthcare Limited
Bombay Stock ExchangeTotal Valuation
Blue Jet Healthcare Limited carries a market capitalization of 100.70B, placing it among publicly traded companies globally. Its enterprise value stands at 152.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 100.70B |
| Enterprise Value | 152.37B |
Valuation Ratios
Blue Jet Healthcare Limited trades at a trailing price-to-earnings ratio of 42.49.
| PE Ratio | 42.49 |
| PS Ratio | 12.47 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Blue Jet Healthcare Limited trades at an EV/EBITDA multiple of 35.07 and an EV/FCF ratio of 26,771.61. The EV/Sales ratio of 12.47 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 35.07 provides insight into valuation relative to core operating earnings.
| EV / Sales | 12.47 |
| EV / EBITDA | 35.07 |
| EV / EBIT | 35.07 |
| EV / FCF | 26,771.61 |
Financial Position
Blue Jet Healthcare Limited maintains a current ratio of 7.17, meaning it holds 7.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.88, indicating elevated leverage, while an interest coverage ratio of 570.90 demonstrates strong ability to service its debt obligations.
| Current Ratio | 7.17 |
| Quick Ratio | 2.64 |
| Debt / Equity | 1.88 |
| Debt / EBITDA | N/A |
| Interest Coverage | 570.90 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 969.49 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Blue Jet Healthcare Limited has paid 1.21B in income taxes, reflecting an effective tax rate of 25.21.
| Income Tax | 1.21B |
| Effective Tax Rate | 25.21 |
Stock Price Statistics
Blue Jet Healthcare Limited's stock has declined approximately -35.62413% over the past 52 weeks. The 50-day moving average sits at 482.09, while the 200-day moving average is 496.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -35.62413% |
| 50-Day Moving Average | 482.09 |
| 200-Day Moving Average | 496.27 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Blue Jet Healthcare Limited generated 12.22B in revenue and converted that into 3.59B in net income, yielding earnings per share of 20.68. EBITDA reached 4.34B, while operating income came in at 4.34B.
| Revenue | 12.22B |
| Gross Profit | 6.52B |
| Operating Income | 4.34B |
| Pretax Income | 4.79B |
| Net Income | 3.59B |
| EBITDA | 4.34B |
| EBIT | 4.34B |
| Earnings Per Share (EPS) | 20.68 |
Margins
Blue Jet Healthcare Limited operates with a gross margin of 53.32, reflecting its pricing power and cost economics. The operating margin of 35.56 and net profit margin of 29.35 provide insight into operational efficiency.
| Gross Margin | 53.32 |
| Operating Margin | 35.56 |
| Pretax Margin | 39.24 |
| Profit Margin | 29.35 |
| EBITDA Margin | 35.56 |
Scores
Blue Jet Healthcare Limited posts an Altman Z-Score of 57.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 57.81 |